Home
HelpTest Code Billings Clinic: 8045 Mayo: TAMIK Amikacin, Trough, Serum
Reporting Name
Amikacin, Trough, SPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Useful For
Monitoring adequate clearance of amikacin near the end of a dosing cycle
Method Name
Kinetic Interaction of Microparticles in Solution (KIMS)
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Serum gel tubes should be centrifuged within 2 hours of collection.
2. Red-top tubes should be centrifuged, and the serum aliquoted into a plastic vial within 2 hours of collection.
Specimen Type
SerumSpecimen Minimum Volume
0.25 mL
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Serum | Refrigerated (preferred) | 14 days | |
| Frozen | 28 days | ||
| Ambient | 72 hours |
Reject Due To
| Gross hemolysis | Reject |
Reference Values
Trough: <8.0 mcg/mL
Toxic trough: >10.0 mcg/mL
Interpretation
For conventional (nonpulse) dosing protocols, trough concentrations should fall to <8.0 mcg/mL. Toxicity may occur if the trough serum concentration is maintained >10.0 mcg/mL for prolonged periods of time.
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 dayTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
80150
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| TAMIK | Amikacin, Trough, S | 3321-7 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| TAMIK | Amikacin, Trough, S | 3321-7 |
Forms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.